微电生理跌2.05%，成交额7290.98万元，主力资金净流出869.12万元

Core Viewpoint - The stock of Microelectrophysiology has experienced fluctuations, with a recent decline of 2.05% and a year-to-date increase of 25.53% [1][2]. Company Overview - Shanghai Microelectrophysiology Medical Technology Co., Ltd. was established on August 31, 2010, and went public on August 31, 2022. The company specializes in innovative medical devices for electrophysiological intervention and ablation treatment [2]. - The revenue composition of the company includes catheter products (71.77%), other products (20.22%), equipment (7.24%), and leasing services (0.77%) [2]. Financial Performance - For the period from January to September 2025, the company achieved a revenue of 336 million yuan, representing a year-on-year growth of 15.65%. The net profit attributable to the parent company was 41.92 million yuan, with a slight increase of 0.46% year-on-year [2]. Stockholder Information - As of September 30, 2025, the number of shareholders increased to 9,580, while the average circulating shares per person decreased by 8.26% to 13,033 shares [2]. - The top circulating shareholders include: - Huatai-PineBridge Innovation Medicine Mixed A (006113) as the largest shareholder with 4.7284 million shares, an increase of 308,600 shares from the previous period [3]. - Huatai-PineBridge Medical Service Flexible Allocation Mixed A (001417) as the second-largest shareholder with 4.2609 million shares, a decrease of 298,360 shares [3]. - Hong Kong Central Clearing Limited entered as a new shareholder with 1.8701 million shares [3].